Lesion Targeting Seems to Be the Secret in Critical Ischemia

Ulcers that do not heal, thus threatening the integrity of a lower limb in patients with critical ischemia, is a main concern. Sometimes, despite successful revascularization, major amputation cannot be prevented.

Apuntar a la lesión parece el secreto de la isquemia crítica

The anatomical description of angiosomes started in the 70s as a way of optimizing tissue grafts. Angiosomes are basically blocks of tissue that include skin, subcutaneous tissue, fascia, muscle, and bone fed by a specific artery and drained by a specific vein.


Read also: Pharmacological balloons in femoropopliteal territory passed time testing.


This concept was then adapted to peripheral revascularization, resulting in the description of 6 angiosomes in foot and leg fed by the three infrapatellar arteries (anterior tibial artery, posterior tibial artery, and fibular artery). Depending on ulcer location, revascularization can be direct (according to the angiosome) or indirect. Whether direct revascularization offers better chances of salvaging the lower limb, as opposed to indirect revascularization with good collaterals, is still unclear.

 

This study included 212 patients who underwent infrapopliteal balloon angioplasty from 2014 to 2016. Propensity score matching was used to compare complete ulcer healing, 1-year amputation-free survival, and limb salvage rates between the two study groups (direct revascularization vs. indirect revascularization).

 

Direct flow to the wound based on the angiosome principle was achieved in 117 lower limbs (55.2%) versus 95 lower limbs (44.8%) in the indirect revascularization group. Seventy-three matched pairs of patients were obtained to minimize intergroup differences.


Read also: What is the effect of statins on amputations, and survival in peripheral vascular disease?


At 12 months, the complete wound healing rates were 80.8% vs. 63.0% (p = 0.02), amputation-free survival rates were 72.6% vs. 61.6% (p = 0.164), and limb salvage rates were 90.4% vs. 82.2% (p = 0.148) in the direct revascularization vs. indirect revascularization groups, respectively.

 

Conclusion

This study suggests that complete ulcer healing rates are better when the affected area receives direct revascularization, whereas limb salvage and amputation-free survival rates were not significantly different.

 

Editorial

Angiosome-guided revascularization is not always possible in surgery due to the presence of infection in the area or a small outflow tract. In these cases, angioplasty can be a very good option, offering the possibility of indirect revascularization in case of procedural failure (an option that has offered similar limb salvage rates). We would start with infrapatellar angioplasty guided by ulcer angiosome and, if direct revascularization were not possible, we would try and use any other feasible artery.

 

The presence of diabetes (in >70% of patients in this study) is associated with a reduction in angiosome collaterals, and it would constitute the greatest limiting factor for indirect revascularization.

 

Original title: A Prospective Study to Evaluate Complete Wound Healing and Limb Salvage Rates  After Angiosome Targeted Infrapopliteal Balloon Angioplasty in Patients with Critical Limb Ischaemia.

Reference: Ahmed Elbadawy et al. Eur J Vasc Endovasc Surg. 2018 Jan 16. Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

TCT 2024 | PEERLESS: Mechanical Thrombectomy with FlowTriever vs Catheter-Directed Thrombolysis in Intermediate Risk PTE

Pulmonary embolism (PE) continues to be the third cause of cardiovascular mortality. The current clinical guidelines recommend anticoagulation in intermediate risk patients presenting right...

Atherosclerotic Renal Artery Stenosis: To Revascularize or Not

At long term, atherosclerotic renal artery stenosis (RAS) can lead to hypertension, chronic kidney disease, and cardiac failure. Historically, these patients have been referred...

Endovascular Management of Chronic TEPH: Is Coronary Management Extrapolatable in This Scenario?

Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition that causes significant functional limitation. Its surgical treatment, known as pulmonary endarterectomy (PEA), has improved the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...